Bangladesh Reaffirms Commitment to Peaceful Nuclear Technology for Cancer Care
Bangladesh has reaffirmed its commitment to using nuclear science and technology for cancer treatment and broader healthcare, highlighting the role of peaceful nuclear applications in addressing the country's growing cancer burden.
Science and Technology Minister Fakir Mahbub Anam made the commitment while addressing the International Atomic Energy Agency (IAEA) Scientific Forum 2026 in Vienna on September 15. The forum, titled “Rays of Hope: Delivering on the Promise of Cancer Care,” focused on expanding access to cancer prevention, diagnosis and treatment through nuclear science.
The announcement is significant because Bangladesh is seeking to expand cancer care beyond individual treatment facilities and build a more integrated system covering prevention, early detection, diagnosis, treatment, quality assurance and palliative care.
Bangladesh Links Nuclear Technology With Cancer Care
According to the minister's remarks, Bangladesh wants peaceful applications of nuclear science and technology to become a stronger part of its response to the country's cancer burden.
The government also emphasized cooperation with the IAEA's Rays of Hope initiative, which aims to expand access to quality cancer care, particularly in countries where radiotherapy and nuclear medicine capacity remains limited.
This does not mean nuclear technology is being used only for cancer treatment. Nuclear medicine can support both diagnosis and therapy through radioactive materials and specialized imaging systems.
Bangladesh Atomic Energy Commission (BAEC) facilities already use technologies such as PET-CT and SPECT-CT for medical imaging. BAEC describes nuclear medicine as a peaceful application of nuclear energy in which radiation from radioisotopes can help diagnose diseases and, in selected cases, provide treatment.
Why Nuclear Medicine Matters in Cancer Treatment
Nuclear medicine differs from conventional imaging because it can provide information about how tissues and organs function, rather than only showing their physical structure.
For cancer patients, technologies such as PET-CT can help doctors identify abnormal metabolic activity and assess the spread of certain cancers. Other nuclear medicine techniques can be used to evaluate whether particular treatments may be appropriate.
This makes access to nuclear medicine important at several stages of cancer care.
Early and accurate diagnosis can help doctors determine the extent of disease, while certain radioactive medicines can be used therapeutically in specific cancers. The appropriate treatment, however, depends on the cancer type, stage and individual patient circumstances.
Bangladesh's National Institute of Nuclear Medicine and Allied Sciences and other BAEC facilities already provide nuclear medicine services. BAEC's Dhaka Medical College facility, for example, lists PET-CT, SPECT-CT and other diagnostic technologies among its services.
IAEA Cooperation Could Strengthen Bangladesh's Healthcare Capacity
Bangladesh's latest commitment also fits into a broader cooperation framework with the IAEA.
In March 2026, Bangladesh and the IAEA signed the country's Fifth Country Programme Framework (CPF) for 2026–2032. The framework identifies seven priority areas, including human health, nuclear and radiation safety, energy, food and agriculture, water and environment, nuclear knowledge and radiation technology in industry.
The agreement provides a medium-term framework for technical cooperation between Bangladesh and the IAEA.
For healthcare, such cooperation can involve training, technical assistance, equipment, expertise and development of institutional capacity. This is particularly relevant for cancer care, where sophisticated equipment alone is not enough.
Hospitals also require trained nuclear medicine specialists, medical physicists, radiologists, technologists, nurses and other healthcare professionals.
Bangladesh Already Has a Nuclear Medicine Network
The latest announcement is therefore an extension of an existing healthcare infrastructure rather than a completely new initiative.
BAEC operates nuclear medicine and allied science facilities in different parts of Bangladesh. These institutions provide diagnostic services and are involved in education and research.
The Dhaka Medical College INMAS, for example, traces its origins to a radioisotope centre established in 1961 and now operates advanced diagnostic equipment including PET-CT and SPECT-CT.
BAEC has also been working to expand the domestic supply of medical radioisotopes.
Its Radioisotope Production Division at the Institute of Nuclear Science and Technology in Savar identifies reducing import dependence for radioisotopes and radiopharmaceuticals as one of its objectives. It specifically mentions important radioisotopes such as technetium-99m and iodine-131.
A reliable supply of medical radioisotopes is important because nuclear medicine services depend on the availability of appropriate radioactive materials.
The Next Challenge Is Access, Not Just Technology
For Bangladesh, one of the biggest challenges will be ensuring that advanced cancer technology reaches patients outside major urban centres.
Cancer care involves much more than installing a PET-CT scanner or establishing a nuclear medicine department. Patients need access to screening, pathology, imaging, surgery, radiotherapy, systemic treatment, follow-up care and palliative services.
There is also a geographic and affordability dimension.
If advanced nuclear medicine services remain concentrated in a small number of facilities, patients in rural or lower-income communities may still face significant barriers.
That explains why Bangladesh's emphasis on an integrated and equitable cancer-care system is important. The minister's statement at the IAEA forum specifically highlighted prevention, early detection, diagnosis, treatment, skilled human resources, quality assurance and palliative care as interconnected elements of patient-centred cancer services.
Safety and Regulation Remain Central
The expansion of nuclear technology in healthcare also requires strict radiation safety and security standards.
Bangladesh has reiterated that peaceful nuclear applications must be accompanied by appropriate safety, security and responsible management. Its broader cooperation with the IAEA includes nuclear and radiation safety and security as a priority under the 2026–2032 framework.
This is particularly important as nuclear medicine expands. Radioactive materials must be produced, transported, stored and administered under controlled conditions, while medical facilities require appropriate radiation protection systems.
The goal is therefore not simply to increase the number of nuclear medicine facilities but to build a system that is medically effective, safe and sustainable.
What Bangladesh's Nuclear Healthcare Push Could Mean
The immediate significance of the policy is healthcare, but there are wider implications for Bangladesh's science and technology ecosystem.
Greater use of nuclear medicine could create demand for:
Medical physicists and nuclear medicine specialists
Radiopharmaceutical production
Diagnostic imaging infrastructure
Radiation safety equipment
Research and training
Hospital-based nuclear medicine services
International technical cooperation
The development of domestic radioisotope capabilities could also reduce vulnerabilities associated with imported medical materials over time, although achieving greater self-sufficiency requires sustained investment, technical expertise and quality-control systems.
For the healthcare sector, the more important measure will ultimately be patient outcomes and access rather than the number of machines installed.
What to Watch Next
The next phase will be whether Bangladesh can translate its international commitments into expanded services on the ground.
Key areas to monitor include the implementation of the 2026–2032 IAEA Country Programme Framework, expansion of nuclear medicine and radiotherapy capacity, development of skilled healthcare professionals, availability of radiopharmaceuticals and progress under the IAEA's Rays of Hope programme.
The implementation of Bangladesh's existing nuclear medicine projects will also matter. BAEC lists an IAEA technical-cooperation project for 2026–2027 focused on strengthening diagnostic and therapeutic nuclear medicine facilities for cancer treatment in Bangladesh.
Key Takeaway
Bangladesh's latest statement at the IAEA signals a continued effort to use peaceful nuclear technology as part of its cancer-care strategy. The country already has nuclear medicine infrastructure and decades of cooperation with the IAEA, while its new 2026–2032 cooperation framework creates additional scope for technical support.
The real test will be implementation: whether advanced diagnosis and treatment can become more widely available, whether the country can strengthen its specialist workforce and radiopharmaceutical supply, and whether cancer care can reach patients beyond major urban centres.
Follow the blog for more updates on healthcare technology, science, business and emerging industries.
This article is for informational and educational purposes only and should not be considered medical or investment advice.